Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/75859
DC Field | Value | Language |
---|---|---|
dc.contributor | Department of Applied Biology and Chemical Technology | - |
dc.contributor | Chinese Mainland Affairs Office | - |
dc.creator | Yang, X | - |
dc.creator | Luo, MJ | - |
dc.creator | Yeung, ACM | - |
dc.creator | Lewis, PJ | - |
dc.creator | Chan, PKS | - |
dc.creator | Ip, M | - |
dc.creator | Ma, C | - |
dc.date.accessioned | 2018-05-10T02:54:47Z | - |
dc.date.available | 2018-05-10T02:54:47Z | - |
dc.identifier.issn | 0006-2960 | - |
dc.identifier.uri | http://hdl.handle.net/10397/75859 | - |
dc.language.iso | en | en_US |
dc.publisher | American Chemical Society | en_US |
dc.rights | © 2017 American Chemical Society | en_US |
dc.rights | This document is the Accepted Manuscript version of a Published Work that appeared in final form in Biochemistry, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acs.biochem.7b00349. | en_US |
dc.title | First-in-class inhibitor of ribosomal RNA synthesis with antimicrobial activity against staphylococcus aureus | en_US |
dc.type | Journal/Magazine Article | en_US |
dc.identifier.spage | 5049 | - |
dc.identifier.epage | 5052 | - |
dc.identifier.volume | 56 | - |
dc.identifier.issue | 38 | - |
dc.identifier.doi | 10.1021/acs.biochem.7b00349 | - |
dcterms.abstract | We report the discovery of the first bacterial ribosomal RNA (rRNA) synthesis inhibitor that has specific antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA). A pharmacophore model was constructed on the basis of the proteinprotein interaction between essential bacterial rlINA transcription factors NusB and NusE and employed for an in silico screen to identify potential leads. One compound, (E)-2-{[(3-ethynylphenyl)imino]methyl}-4-nitrophenol (MC4); demonstrated antimicrobial activity against a panel of S. aureus strains, including MRSA, without significant toxicity to mammalian cells. MC4 resulted in a decrease in the rRNA level in bacteria, and the target specificity of MC4 was confirmed at the molecular level. Results obtained from this work validated the bacterial rRNA transcription machinery as a novel antimicrobial target. This approach may be extended to other factors in rRNA transcription,.. and MC4 could be applied as a chemical probe to dissect the relationship among MRSA infection, MRSA, growth rate, and rRNA synthesis, in addition to its therapeutic potential. | - |
dcterms.accessRights | open access | - |
dcterms.bibliographicCitation | Biochemistry, 26 Sept. 2017, v. 56, no. 38, p. 5049-5052 | - |
dcterms.isPartOf | Biochemistry | - |
dcterms.issued | 2017-09-26 | - |
dc.identifier.isi | WOS:000411918000004 | - |
dc.identifier.scopus | 2-s2.0-85029955336 | - |
dc.identifier.pmid | 28782938 | - |
dc.identifier.rosgroupid | 2017000178 | - |
dc.description.ros | 2017-2018 > Academic research: refereed > Publication in refereed journal | - |
dc.description.validate | 201805 bcrc | - |
dc.description.oa | Accepted Manuscript | - |
dc.identifier.FolderNumber | a0734-n01 | - |
dc.identifier.SubFormID | 1300 | - |
dc.description.fundingSource | Others | - |
dc.description.fundingText | P0001178, P0020297 | - |
dc.description.pubStatus | Published | - |
Appears in Collections: | Journal/Magazine Article |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
a0734-n01_1300.pdf | Pre-Published version | 1.8 MB | Adobe PDF | View/Open |
Page views
98
Last Week
0
0
Last month
Citations as of Mar 24, 2024
Downloads
94
Citations as of Mar 24, 2024
SCOPUSTM
Citations
16
Last Week
1
1
Last month
Citations as of Mar 28, 2024
WEB OF SCIENCETM
Citations
16
Last Week
0
0
Last month
Citations as of Mar 28, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.